BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 14550707)

  • 1. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
    Cunnick GH; Mokbel K
    Lancet; 2003 Oct; 362(9390):1154; author reply 1155-6. PubMed ID: 14550707
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
    Zammit C; Yelland A; Deutsch G
    Lancet; 2003 Oct; 362(9390):1154; author reply 1155-6. PubMed ID: 14550708
    [No Abstract]   [Full Text] [Related]  

  • 3. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
    Baroni G; Pedotti A; Orecchia R
    Lancet; 2003 Oct; 362(9390):1155; author reply 1155-6. PubMed ID: 14550709
    [No Abstract]   [Full Text] [Related]  

  • 4. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
    Yau T; Epstein RJ
    Lancet; 2003 Oct; 362(9390):1154-5; author reply 1155-6. PubMed ID: 14550706
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ.
    Tjalma WA
    Lancet; 2003 Oct; 362(9390):1156-7. PubMed ID: 14550711
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-surgical management of early breast cancer in the United Kingdom: ductal carcinoma in situ. Clinical Audit Sub-committee of the Faculty of Clinical Oncology, Royal College of Radiologists, and the Joint Council for Clinical Oncology.
    Spittle M; Stewart HJ
    Clin Oncol (R Coll Radiol); 1995; 7(4):217-8. PubMed ID: 8845314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is radiotherapy boost needed in young patients with ductal carcinoma-in-situ?
    Wong JS
    Lancet Oncol; 2006 Aug; 7(8):615-7. PubMed ID: 16887475
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
    Yen TW; Kuerer HM; Ottesen RA; Rouse L; Niland JC; Edge SB; Theriault RL; Weeks JC
    J Clin Oncol; 2007 Aug; 25(22):3251-8. PubMed ID: 17577019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of radiation therapy after local excision of invasive and noninvasive breast cancer.
    Marks LB; Prosnitz LR
    Surg Oncol Clin N Am; 1997 Apr; 6(2):359-79. PubMed ID: 9115501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Local recurrence of ductal in situ carcinoma of the breast].
    Dunst J
    Strahlenther Onkol; 1999 Jul; 175(7):348-9. PubMed ID: 10432998
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer (non-metastatic).
    Dixon JM; Rodger A; Stebbing J
    Clin Evid; 2005 Jun; (13):2226-57. PubMed ID: 16135326
    [No Abstract]   [Full Text] [Related]  

  • 12. Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
    Margolese RG; Cecchini RS; Julian TB; Ganz PA; Costantino JP; Vallow LA; Albain KS; Whitworth PW; Cianfrocca ME; Brufsky AM; Gross HM; Soori GS; Hopkins JO; Fehrenbacher L; Sturtz K; Wozniak TF; Seay TE; Mamounas EP; Wolmark N
    Lancet; 2016 Feb; 387(10021):849-56. PubMed ID: 26686957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal carcinoma in situ--current management.
    O'Sullivan MJ; Morrow M
    Surg Clin North Am; 2007 Apr; 87(2):333-51, viii. PubMed ID: 17498530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer (non-metastatic).
    Rodger A; Stebbing J; Thompson AM
    Clin Evid; 2006 Jun; (15):2360-92. PubMed ID: 16973090
    [No Abstract]   [Full Text] [Related]  

  • 15. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.
    Overgaard M; Jensen MB; Overgaard J; Hansen PS; Rose C; Andersson M; Kamby C; Kjaer M; Gadeberg CC; Rasmussen BB; Blichert-Toft M; Mouridsen HT
    Lancet; 1999 May; 353(9165):1641-8. PubMed ID: 10335782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ductal in situ carcinoma: is it ethical to consider the breast conserving therapy as a standard?].
    Barillot I; Cutuli B; Arnould L
    Cancer Radiother; 2004 Feb; 8(1):9-20. PubMed ID: 15093196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853].
    Noël G; Mazeron JJ
    Cancer Radiother; 2001 Apr; 5(2):193-4. PubMed ID: 11355583
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tumorectomy plus irradiation in ductal in-situ carcinoma].
    Dunst J
    Strahlenther Onkol; 1996 Jun; 172(6):344-5. PubMed ID: 8677509
    [No Abstract]   [Full Text] [Related]  

  • 19. Breast conservation therapy in the management of invasive and in situ carcinoma.
    Masko GB; Triedman SA; Brotman RL; Webber BM; Yu A
    R I Med; 1995 Sep; 78(9):246-9. PubMed ID: 7579719
    [No Abstract]   [Full Text] [Related]  

  • 20. [Breast carcinoma in accessory gland: a case report].
    Sivelli R; Del Rio P; Arcuri MF; Corcione L
    G Chir; 2002 May; 23(5):179-80. PubMed ID: 12228967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.